Foundation for Sarcoidosis Research
Sarcoidosis Journal Club
FSR Global Sarcoidosis Clinic Alliance (FSR-GSCA) is pleased to announce the second FSR Sarcoidosis Journal Club (SJC) CME, on April 12, 2023, from 4:30-5:30pm CST. We are honored to have Cedars-Sinai Medical Center co-hosting this virtual session.
Registration is for FSR-GSCA member clinics only and is required.
This CME program is offered to all attendees at no charge. The SJC will be recorded, and available to all Alliance Members for future viewing.
April Publication
Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis
Authors: Abdullah Sakkat, Gerard Cox, Nader Khalidi, Maggie Larche, Karen Beattie, Elisabetta A. Renzoni, Nilesh Morar, Vasilis Kouranos, Martin Kolb & Nathan Hambly
The goal of the FSR Sarcoidosis Journal Club is to improve patient care by incorporating evidence into practice. This innovative series is brought to you by the FSR-GSCA, exclusively for FSR-GSCA member clinics.
Join experts, fellows, and residents at this virtual event and gain knowledge in advancements in sarcoidosis and awareness of current research findings.
FSR Sarcoidosis Journal Club Format:
-Virtual Platform
30 minutes: Publication Review
25 minutes: Discussion
5 minutes: Closing Remarks
-Attendees: Registration is Required
-CME credits are available to all participants attending the live event
-Attendees will be expected to complete a short post-session survey
-The SJC will be recorded, and available to all Alliance Members for future viewing
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Florida College of Medicine and the Foundation for Sarcoidosis Research. The University of Florida College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit: The University of Florida College of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Thank you to Boehringer Ingelheim and Mallinckrodt Pharmaceuticals for supporting FSR's educational mission.
